Session Information
2009 Midyear Clinical Meeting
Click here to go to the previous page
Getting to the Heart of the Matter: The Link between Diabetes and Heart Failure
Track:
Educational Sessions (CE)
Program Code: 278-L01
Date: Thursday, December 10, 2009
Time: 2:00 PM to 4:00 PM EST
Location:
3104 - Lido
MEETING PLANNING ASSOCIATE:
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
Tracy Martinez, PharmD, BCPS, Ambulatory Care Clinical Pharmacist, John D. Dingell VA Medical Center
PRESENTER(S):
Click the plus sign to see more detailed information about each speaker.
Click the plus sign to see more detailed information about each speaker.
Tracy Martinez, PharmD, BCPS, Ambulatory Care Clinical Pharmacist, John D. Dingell VA Medical Center
Description
Planned in cooperation with the ASHP Section of Home, Ambulatory, and Chronic Care Practitioners
ACPE Activity #204-000-09-278-L01P
2.0 Contact Hours / Knowledge-based
Educational Content: Level 3
Moderator: Tracy Anne Martinez, PharmD, BCPS, Ambulatory Care Clinical Pharmacist, John D. Dingell VA Medical Center, Detroit, MI
2:00 p.m. – 2:05 p.m.
Announcements
2:05 p.m. – 2:25 p.m.
Diabetes and Heart Failure: General Pathophysiology, Epidemiology, and the Link between These Diseases
Linda A. Jaber, PharmD, Professor, Wayne State University, Detroit, MI
2:25 p.m. – 2:45 p.m.
Treatment of Heart Failure in Patients with Diabetes: General Considerations
Linda A. Jaber
2:45 p.m. – 3:00 p.m.
Treating Diabetes in Patients with Heart Failure: Controversies and Concerns
Peter Dumo, BSc Pharm, PharmD, Community Pharmacist/Pharmacy Owner, Novacare Pharmacy, Windsor, Ontario, Canada
3:00 p.m. – 3:35 p.m.
Spotlight on Thiazolidinediones (TZDs): Evidence, Concerns and Recommendations
Peter Dumo
3:35 p.m. – 3:45 p.m.
Preventing or Slowing the Development of Heart Failure in Diabetes Patients
Peter Dumo
3:45 p.m. – 4:00 p.m.
Questions, Answers, and Discussion
Learning Objectives:
ACPE Activity #204-000-09-278-L01P
2.0 Contact Hours / Knowledge-based
Educational Content: Level 3
Moderator: Tracy Anne Martinez, PharmD, BCPS, Ambulatory Care Clinical Pharmacist, John D. Dingell VA Medical Center, Detroit, MI
2:00 p.m. – 2:05 p.m.
Announcements
2:05 p.m. – 2:25 p.m.
Diabetes and Heart Failure: General Pathophysiology, Epidemiology, and the Link between These Diseases
Linda A. Jaber, PharmD, Professor, Wayne State University, Detroit, MI
2:25 p.m. – 2:45 p.m.
Treatment of Heart Failure in Patients with Diabetes: General Considerations
Linda A. Jaber
2:45 p.m. – 3:00 p.m.
Treating Diabetes in Patients with Heart Failure: Controversies and Concerns
Peter Dumo, BSc Pharm, PharmD, Community Pharmacist/Pharmacy Owner, Novacare Pharmacy, Windsor, Ontario, Canada
3:00 p.m. – 3:35 p.m.
Spotlight on Thiazolidinediones (TZDs): Evidence, Concerns and Recommendations
Peter Dumo
3:35 p.m. – 3:45 p.m.
Preventing or Slowing the Development of Heart Failure in Diabetes Patients
Peter Dumo
3:45 p.m. – 4:00 p.m.
Questions, Answers, and Discussion
Learning Objectives:
LEARNER OUTCOMES:
- Choose appropriate and safe therapy for treating the individual disease in a patient diagnosed with both heart failure and diabetes.
- Describe treatment strategies for preventing or slowing the development of heart failure in patients with diabetes.
- Explain the link between diabetes and heart failure including the shared pathophysiology.
- Identify reasons why patients with diabetes are more likely to develop heart failure and describe the outcomes seen in such patients.
- Summarize the general pathophysiology and treatment of patients with both diabetes and heart failure.
This session is a part of:
Handout Online
